Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Sant'Anna, R.
  • Gallego, P.
  • Robinson, L. Z.
  • Pereira-Henriques, A.
  • Ferreira, N.
  • Pinheiro, F.
  • Esperante, S.
  • Pallares, I.
  • Huertas, O.
  • Almeida, M. R.
  • Reixach, Natalia
  • Insa, R.
  • Velazquez-Campoy, A.
  • Reverter, D.
  • Reig, N.
  • Ventura, S.

publication date

  • 2016

journal

  • Nature Communications  Journal

abstract

  • Transthyretin (TTR) is a plasma homotetrameric protein implicated in fatal systemic amyloidoses. TTR tetramer dissociation precedes pathological TTR aggregation. Native state stabilizers are promising drugs to treat TTR amyloidoses. Here we repurpose tolcapone, an FDA-approved molecule for Parkinson's disease, as a potent TTR aggregation inhibitor. Tolcapone binds specifically to TTR in human plasma, stabilizes the native tetramer in vivo in mice and humans and inhibits TTR cytotoxicity. Crystal structures of tolcapone bound to wild-type TTR and to the V122I cardiomyopathy-associated variant show that it docks better into the TTR T4 pocket than tafamidis, so far the only drug on the market to treat TTR amyloidoses. These data indicate that tolcapone, already in clinical trials for familial amyloid polyneuropathy, is a strong candidate for therapeutic intervention in these diseases, including those affecting the central nervous system, for which no small-molecule therapy exists.

subject areas

  • Administration, Oral
  • Amyloid Neuropathies, Familial
  • Animals
  • Benzophenones
  • Catechol O-Methyltransferase Inhibitors
  • Cell Line
  • Dimerization
  • Drug Repositioning
  • Healthy Volunteers
  • Humans
  • Mice, Transgenic
  • Middle Aged
  • Nitrophenols
  • Prealbumin
  • Protein Aggregation, Pathological
scroll to property group menus

Identity

PubMed Central ID

  • PMC4766415

International Standard Serial Number (ISSN)

  • 2041-1723

Digital Object Identifier (DOI)

  • 10.1038/ncomms10787

PubMed ID

  • 26902880
scroll to property group menus

Additional Document Info

volume

  • 7

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support